RE:Tesamorelin phase 4 trial!More science and paper that will lead to nothing for shareholders. Greenspoon and the NIH got us a P3 Nash program with their truckload of studies and what now... there is no patent life left in this thing anyway. Maybe they decide to celebrate this at Thera... maybe it’s a ways to push for a label extension in the lipo indication to cover lipo Nash population... I see the angle... maybe it’s a good idea.